Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB15845Experimental
As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony...
- Also known as
- AP-TP-V · COVID-19 AP TP Vaccine · COVID-19 Therapeutic Vaccine - Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
- Code names
- COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
What you can answer from here — as of March 06, 2025
Which companies are running trials of COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection, in which indications and phases, and which of those programs are still active?